| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $5.5B | $1.4B | $5.0B | $1.2B | $0.9B | $0.8B | $0.8B |
| Cost of Revenue | $3.1B | $0.8B | $2.8B | $0.6B | $0.5B | $0.5B | $0.4B |
| Gross Profit | $2.4B | $0.6B | $2.2B | $0.6B | $0.4B | $0.4B | $0.3B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.3B | $1.3B | $1.3B | $1.5B | $0.7B | $0.7B | $0.7B |
| Operating Income | $0.9B | $0.8B | $0.3B | $0.4B | $0.5B | $0.5B | $0.4B |
| Net Income | $0.6B | $-0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.24 | $-0.01 | $1.07 | $0.52 | $1.02 | $1.45 | $1.29 |
| EPS (Diluted) | $6.20 | $-0.01 | $1.07 | $0.52 | $1.02 | $1.44 | $1.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $10.1B | $11.1B | $10.8B | $11.4B | $6.6B | $5.4B | $5.1B |
| Current Assets | $2.0B | $2.9B | $2.0B | $1.9B | $1.2B | $1.2B | $1.1B |
| Cash & Equivalents | — | — | — | — | $0.2B | $0.3B | $0.2B |
| Total Liabilities | $3.5B | $4.7B | $4.7B | $4.9B | $2.7B | $2.0B | $1.9B |
| Current Liabilities | $1.0B | $0.9B | $0.9B | $0.9B | $0.6B | $0.5B | $0.5B |
| Stockholders' Equity | $6.6B | $6.3B | $6.1B | $6.5B | $3.9B | $3.4B | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.0B | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B |
| Investing Cash Flow | $0.4B | $-0.9B | $-0.4B | $-0.7B | $-1.2B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.6B | $-0.1B | $-0.5B | $0.1B | $0.3B | $-0.2B | $-0.3B |